EyeGate Pharma Announces Additional Positive Top-Line Data in PRK Pivotal Study

Go back to EyeGate Pharma Announces Additional Positive Top-Line Data in PRK Pivotal Study
(NASDAQ: EYEG) Delayed: 34.86 -0.08 (0.23%)
Previous Close $34.94    52 Week High $5.09 
Open $34.86    52 Week Low $1.11 
Day High $34.86    P/E N/A 
Day Low $34.86    EPS $0.00 
Volume 110